» Articles » PMID: 34890713

Wnt/β-catenin Signaling and P68 Conjointly Regulate CHIP in Colorectal Carcinoma

Overview
Publisher Elsevier
Date 2021 Dec 10
PMID 34890713
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging evidences suggest abundant expression of Carboxy terminus of Hsc70 Interacting Protein or CHIP (alias STIP1 Homology and U-box Containing Protein 1 or STUB1) in colorectal carcinoma, but the mechanistic detail of this augmented expression pattern is unclear. The signature driver of canonical Wnt pathway, β-catenin, and its co-activator RNA helicase p68, are also overexpressed in colorectal carcinoma. In this study, we describe a novel mechanism of Wnt/β-catenin and p68 mediated transcriptional activation of CHIP gene leading to enhanced proliferation of colorectal carcinoma cells. Bioinformatic analyses reconfirmed an elevated CHIP expression level in colorectal carcinoma datasets. Wnt3A treatment and pharmacological activation of canonical Wnt signaling pathway resulted in increased nuclear translocation of β-catenin, augmenting CHIP expression. Likewise, immunoblotting and Real time PCR following overexpression and knockdown of β-catenin and p68 demonstrated upregulated and downregulated CHIP expression, respectively, at both mRNA and protein levels. p68 along with β-catenin were found to occupy Transcription Factor 4 (TCF4) binding sites on endogenous CHIP promoter and regulate its transcription. After cloning CHIP promoter, the increased and decreased promoter activities of CHIP induced by overexpression and knockdown of either β-catenin or p68 further confirmed transcriptional regulation of CHIP gene by Wnt/β-catenin signaling cascade. Finally, enhanced cellular propagation and migration of colorectal carcinoma cells induced by 'Wnt/β-catenin-p68-CHIP' axis established the significance of this pathway in oncogenesis. To the best of our knowledge, this is the first report elucidating the mechanistic details of transcriptional regulation of CHIP (STUB1) gene expression.

Citing Articles

Regulation of the β‑catenin/LEF‑1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion.

Zhang X, Cui D, Sun W, Yang G, Wang W, Mi C Oncol Rep. 2024; 53(2).

PMID: 39670302 PMC: 11667213. DOI: 10.3892/or.2024.8855.


FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5.

Takeda K, Ohta S, Nagao M, Kobayashi E, Tago K, Funakoshi-Tago M Int J Mol Sci. 2024; 25(7).

PMID: 38612503 PMC: 11011477. DOI: 10.3390/ijms25073693.


Role and therapeutic potential of DEAD-box RNA helicase family in colorectal cancer.

Zheng B, Chen X, Ling Q, Cheng Q, Ye S Front Oncol. 2023; 13:1278282.

PMID: 38023215 PMC: 10654640. DOI: 10.3389/fonc.2023.1278282.


VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma.

Yang S, Zhou P, Zhang L, Xie X, Zhang Y, Bo K Cancer Biol Ther. 2023; 24(1):2230641.

PMID: 37405957 PMC: 10324439. DOI: 10.1080/15384047.2023.2230641.


Three New Compounds, Licopyranol A-C, Together with Eighteen Known Compounds Isolated from L. and Their Antitumor Activities.

Wang S, Alafifi J, Chen Q, Shen X, Bi C, Wu Y Metabolites. 2022; 12(10).

PMID: 36295798 PMC: 9612088. DOI: 10.3390/metabo12100896.